Illumigen Biosciences Inc.

Related by string. * : Illumigen Biosciences . Illumigen / biosciences . bioscience . BioSciences . BIOSCIENCES . BioScience . BIOSCIENCE : IR BioSciences Holdings . Cypress Bioscience Inc. . PURE Bioscience . Cypress Bioscience . Oxford Bioscience / inc . INC. . INC . inc. . Incs : Inc. NASDAQ SCOR . Permissions Group Inc. . Treat Diseases Inc. . Limited Brands Inc. . SBC Communications Inc. * *

Related by context. Frequent words. (Click for all words.) 61 BioMarin Genzyme LLC 59 Pharmion Corporation 59 b Excludes 58 Chronimed 58 MGI PHARMA INC. 58 Excluding goodwill impairment 58 Pro forma EBITDA 58 Trubion Pharmaceuticals 57 ICOS Corporation 57 SangStat 56 Cougar Biotechnology Inc. 56 Esprit Pharma 56 Penwest Pharmaceuticals 56 HLTH Corporation 56 NASDAQ LGND 56 QLT USA 56 early extinguishments 56 3Q FY# 56 Including discontinued operations 56 d Represents 56 NASDAQ BPAX 56 Tolmar 55 Duane Reade Holdings 55 Sciele Pharma 55 Ore Pharmaceuticals 55 Noninterest expense decreased 55 ACLARA 55 ACADIA Pharmaceuticals 55 Minrad 55 Inc. NASDAQ ZGEN 55 Paris EURONEXT SAN 55 PLAVIX R 55 Altus Pharmaceuticals 55 RARE Hospitality International 55 Organon BioSciences NV 55 NASDAQ OSIR 54 Berkeley HeartLab 54 ZALBIN 54 Teleflex Incorporated 54 Inc. NASDAQ RRGB 54 unconsolidated joint 54 discontinued operations - 54 MYBA recently 54 Vicuron Pharmaceuticals 54 Incyte Corporation 54 NovaCardia 54 Barrier Therapeutics Inc. 54 Provident Bankshares 54 Nonperforming assets totaled 54 Novogyne 54 Digene Corporation 54 IOMED 54 Excluding nonrecurring items 54 Xcyte 54 Connetics Corporation 54 Emisphere Technologies 54 VANTAS 54 postretirement benefit 53 Trubion Pharmaceuticals Inc. 53 Ampersand Ventures 53 Company Prospectus dated 53 Progenics Pharmaceuticals 53 Sunesis Pharmaceuticals 53 Unaudited Condensed Consolidated 53 Enzo Biochem 53 AppTec 53 Organon BioSciences 53 Company Nasdaq PRGO 53 Osteocel 53 Behrman Capital 53 Files Shelf Registration Statement 53 Dynogen 53 -DD2 53 pershare 53 Ariad Pharmaceuticals 53 EPIX Pharmaceuticals 53 Esoterix 53 InfrastruX 53 Eyetech Pharmaceuticals Inc. 53 f h 53 DRA Advisors LLC 52 noncash goodwill impairment 52 Symphony Allegro 52 Inc. NYSE OHI 52 postretirement benefit obligations 52 Pro Forma Adjusted EBITDA 52 Abraxis BioScience Inc. 52 CRIIMI MAE 52 Inergy Holdings 52 Sturm Foods 52 Corus Pharma 52 c Represents 52 purchased intangible assets 52 Tepnel 52 ARM INC. 52 BioVeris 52 Facet Biotech Corporation 52 Targeted Genetics Corporation 52 Interest Income Expense 52 MeriStar 52 NASDAQ AMAG

Back to home page